July 2023 in “Clinical and Experimental Dermatology” Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.
November 2023 in “JEADV Clinical Practice” Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.
July 2023 in “LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)” Copaiba resin oil shows promise for cancer therapy and is safe for topical use.
4 citations
,
April 2013 in “International Journal of Pharmaceutical Sciences and Drug Research” Banana plant extract effectively kills worms.
January 2025 in “Skin Health and Disease” Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.
October 2024 in “Canadian Journal of Health Technologies” Olumiant should be covered for severe alopecia areata if certain conditions are met.
February 2024 in “Therya notes” A bat in Veracruz, México, was found with hair loss likely due to an injury and infection.
January 2023 in “Editora Enterprising eBooks” Male pattern baldness has a significant psychological impact on those affected.
November 2024 in “SKIN The Journal of Cutaneous Medicine” Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.
14 citations
,
March 2022 in “Journal of inflammation research” Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.
Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.
July 2023 in “RCMOS - Revista Científica Multidisciplinar O Saber” Scalp therapy in barbershops boosts service quality and business opportunities in men's grooming.
Baricitinib may not always prevent relapse in alopecia areata.
October 2025 in “Editora Pasteur eBooks”
December 2023 in “Journal of Cosmetic Dermatology” Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.
January 2026 in “Experimental Dermatology” Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.
4 citations
,
October 2000 in “Contraception” The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.
October 2022 in “Amplla Editora eBooks”
3 citations
,
February 2022 in “Rheumatology” Baricitinib was effective in treating a patient with dermatomyositis and hair loss.
1 citations
,
January 2025 in “Annals of Dermatology” Baricitinib is effective and safe for treating alopecia areata in Korea.
January 2024 in “Case Reports in Dermatological Medicine” Baricitinib may effectively treat nail changes in alopecia areata.
September 2023 in “Dermatology and Therapy” Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.
October 2022 in “Portuguese Journal of Dermatology and Venereology” The document's conclusion cannot be determined.
6 citations
,
April 2020 in “Cureus” Platelet-rich plasma injections can effectively treat alopecia areata barbae.
Baricitinib shows promise for treating alopecia areata with mild side effects.
November 2025 in “SKIN The Journal of Cutaneous Medicine” Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.
January 2026 in “Biomedical and Biopharmaceutical Research” Pequi and buriti oils improve curly hair's gloss and strength.
June 2024 in “Frontiers in immunology” Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.
July 2008 in “Hair transplant forum international” The document cannot be understood or processed.